| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects
|
Cheung, Dorothy
|
|
|
69 |
C |
p.
|
artikel
|
| 2 |
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study
|
Rogliani, Paola
|
|
|
69 |
C |
p.
|
artikel
|
| 3 |
Diallyl disulfide prevents cigarette smoke-induced emphysema in mice
|
Cardoso, Aline de Oliveira Pontes
|
|
|
69 |
C |
p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
69 |
C |
p.
|
artikel
|
| 5 |
Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19
|
Fisk, Marie
|
|
|
69 |
C |
p.
|
artikel
|
| 6 |
Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-κB signals in OVA-induced asthmatic mice
|
Luo, Yujiao
|
|
|
69 |
C |
p.
|
artikel
|
| 7 |
Hypoxia-induced antizyme inhibitors 2 regulates cisplatin resistance through epithelia-mesenchymal transition pathway in non-small cell lung cancer
|
Shi, Qin
|
|
|
69 |
C |
p.
|
artikel
|
| 8 |
Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study
|
Villamañán, Elena
|
|
|
69 |
C |
p.
|
artikel
|
| 9 |
Retraction notice to Docosahexaenoic acid attenuates hypoxic pulmonary vasoconstriction by activating the large conductance Ca2+-activated K+ currents in pulmonary artery smooth muscle cells [Pulm. Pharmacol. Therap., 28/1 (2013) 9–16]
|
Yan, Jinchuan
|
|
|
69 |
C |
p.
|
artikel
|
| 10 |
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination
|
Robaina Cabrera, Carmen Lorena
|
|
|
69 |
C |
p.
|
artikel
|
| 11 |
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience
|
Benfante, Alida
|
|
|
69 |
C |
p.
|
artikel
|
| 12 |
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
|
Maslennikov, Roman
|
|
|
69 |
C |
p.
|
artikel
|
Tijdschrift beschrijving